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Abstract
Diesel exhaust particles (DEPs) are the main components of ambient particulate materials, including polyaromatic
hydrocarbons (PAHs), n-PAHs, heavy metals, and gaseous materials. Many epidemiological, clinical, and toxicological studies
have shown that ambient particles, including DEPs, are associated with respiratory disorders, such as asthma, allergic rhinitis,
and lung cancer. However, the relationship between the biological response to DEPs and their chemical composition remains
unclear. In this study, we investigated the physicochemical properties of DEPs before toxicological studies, and then
administered a single intratracheal instillation of DEPs to mice. The mice were then killed 1, 7, 14 and 28 days after DEP
exposure to observe the biological responses induced by DEPs over time. Our findings suggest that DEPs engulfed into cells
induced a Th2-type inflammatory response followed by DNA damage, whereas DEPs not engulfed into cells induced a Th1-
type inflammatory response. Further, the physicochemical properties, including surface charge, particle size, and chemical
composition, of DEPs play a crucial role in determining the biological responses to DEPs. Consequently, we suggest that the
biological response to DEPs depend on cell-particle interaction and the physicochemical properties of the particles.
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Introduction
Ambient particles are known as both initiators and enhancers of
the clinical manifestations of both allergic and non-allergic airway
disease in industrialized countries, and diesel exhaust particles
(DEPs) are one of main components of ambient particles. DEP
exposure can induce acute irritation of the eyes and throat, light-
headedness, and nausea. Further, they have been associated with
the worsening of respiratory symptoms, such as cough, phlegm,
chronic bronchitis, and asthma. Epidemiologic studies also
suggested a strong link between DEP exposure and detrimental
health concerns, including cardiopulmonary morbidity and mor-
tality [1,2,3].
It has been established that DEPs are known to generate
reactive oxygen species (ROS) on intracellular uptake, and ROS
generation is attributed to the chemical composition of the
particles, such as transition metals and organic chemicals. ROS
generated by DEP exposure can also lead to oxidative stress, which
in turn triggers a variety of cellular consequences, such as DNA
damage, apoptosis, inflammatory responses, and antioxidant
defense activation/depletion [4,5,6,7,8].
The incidence of allergic airway disease has increased in parallel
with the increasing use of fossil fuels. Data collected until 2009
shows that asthma is a problem worldwide, affecting an estimated
300 million individuals (Global Initiative for Asthma, GINA).
DEPs act deeply in the nasal epithelium by directing cytokine gene
expression toward a Th2 profile, enhancing local antigen-specific
immunoglobulin (Ig) E production and driving in vivo isotype
switch to IgE production [9]. Additionally, DEPs interfere with not
only the maturation but also the function of dendritic cells, thus
suggesting that DEPs play a role in Th2-type immune deviations
[10]. Lungs of mice repeatedly exposed to DEPs plus ovalbumin
(OVA) showed higher expression of major histocompatibility
complex (MHC) class II cells and cells expressing CD11c,
DEC205, CD80, CD86, F4/80, and CD19 than those of mice
exposed to the vehicle, DEPs, or OVA. In addition, splenic
mononuclear cells primed by DEPs plus OVA produced a greater
amount of interleukin (IL)-4, IL-5, and IL-13 after in vitro antigen
stimulation than those primed by vehicle, DEPs, or OVA [11].
DEPs also significantly suppressed mRNA expression and protein
production of interferon (IFN)-c, but did not affect those of IL-4
and IL-5 [12]. In addition, polyaromatic hydrocarbons (PAHs)
have been extracted from DEPs, and DEPs enhanced B-cell
differentiation both in vitro and in vivo [13]. PAHs from roadside
emission also significantly enhanced cytokine secretion (IL-4 and
IL-8) and histamine release from purified basophils [14].
Furthermore, several studies have indicated that DEP exposure
is associated with oxidative damage to DNA, and this might be
associated with an increased risk of cancer [4,15,16,17]. In a
previous study, DEP exposure was shown to downregulate the
expression of murine double minute 2 (Mdm2) protein, a negative
regulator of p53, and upregulate the expression of Bax, a pro-apoptotic
protein and endogenous target of p53-dependent transcriptional
activation [18]. Additionally, exposure of human airway epithelial
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detectable miRNAs (62.9%) by at least 1.5-fold. Molecular network
analysis of the putative targets of the 12 most-altered miRNAs
indicated that DEPs exposure is associated with inflammatory
response pathways and a strong tumorigenic disease signature
[19,20]. Human–hamster hybrid cells exposed to DEPs also
exhibited a dose-dependent increase in the mutation yield at the
CD59 locus, with minimal cytotoxicity [20].
To date, the relationship between the physicochemical properties
of DEPs and the biological response triggered by exposure to DEPs
remains unclear, despite ample evidence on the adverse health
effects of DEPs. In this study, we first investigated the physico-
chemical properties of DEPs before proceeding with toxicological
studies; for the latter, mice were administered DEPs via a single
intratracheal instillation, and the biological responses on days 1, 7,
14, and 28 were evaluated by postmortem examination.
Materials and Methods
Animal and housing conditions
Five-week-old ICR mice were purchased from Orient Bio Inc.
(Gyeonggi-do, Korea) and were acclimated to room conditions for
2 weeks before the initiation of the study. The environmental
conditions were controlled at a constant temperature of 2363uC,
relative humidity of 55610%, and 12-h light/dark cycle with light
of intensity 150–300 lx, and ventilation 10–20 times/h. Three
animals were housed in each suspended, stainless-steel wire cage
(25564656200 mm
3) during the acclimation, pretreatment, and
treatment periods. Each animal was identified by a tail tattoo and
a cage card. Gamma-ray-irradiated standard laboratory rodent
pellet diet (PMI Nutrition International, Richmond, IN, USA) and
municipal tap water sterilized by ultraviolet light were provided to
the animals ad libitum. All experiments were performed in
accordance with the guidelines and regulations of the Korea
Institute of Toxicology and were approved by the Institutional
Animal Care and Use Committee (IACUC) (Approval Number:
BJ09060). All animal facilities in this study were accredited by the
Association for Assessment and Accreditation of Laboratory
Animal Care International (AAALAC).
DEP analysis
Morphological properties of DEP were observed by a high-
resolution transmission electron microscope (HRTEM; JEM-3010,
JOEL, Japan) and an electrophoretic light-scattering spectroscope
(ELS; ELS-8000, Otsuka electronics, Japan). The chemical
composition of DEPs was ascertained by the analysis of an
energy-dispersive X-ray spectroscope (EDS; Oxford instruments,
England) and a fourier transform infrared (FT-IR) spectroscope
(Nicolet 6700, Thermo scientific, USA).
Intratracheal instillation and sample preparation
To study the time course of response to DEP exposure, mice
were treated with DEPs or phosphate buffered saline (PBS).
Intratracheal instillation was performed by a qualified technician
from the Korea Institute of Toxicology, one of the GLP institutes
in Korea, and mice were administered DEPs using a 24-gauge
catheter at a dose of 100 mg/kg under light anesthesia induced by
tiletamine. The animals were killed 1, 7, 14, or 28 days after
exposure. The control group comprised 4 mice treated with PBS.
The body weights of the control and DEP-treated mice were
measured before exposure and before necropsy on days 1, 7, 14,
and 28 after treatment. At the selected time intervals, 1.2-ml blood
samples were collected from the saphenous vein of each mouse
after treatment. The blood samples harvested from the four mice
were pooled to make 1 test sample, yielding 4 test samples
separately from sixteen mice for further analysis for the cell count,
cell phenotype, cytokine concentration, and histamine concentra-
tion (n=4). Whole blood was centrifuged at 3,000 rpm for 10 min
to prepare serum, and 500–600 mL of serum was obtained from
each mouse. Bronchoalveolar lavage (BAL) fluid was obtained by
cannulating the trachea and lavaging the lungs with 1 ml of cold
sterile PBS (0.15 M, pH 7.2) free of Ca
2+ and Mg
2+; approxi-
mately 500–600 mL of BAL fluid was harvested per mouse,
centrifuged at 3,000 rpm for 10 min, and analyzed for cell count
and cytokine concentration.
BAL fluid analysis
Total cells in the BAL fluid were quantified by hemocytometric
counting, with cell differentials performed on cytocentrifuged
preparations fixed in methanol and stained with Diff-Quick
(Thermo Shandon, PA, USA). Distributions of the alveolar
macrophages, neutrophils, and lymphocytes were assessed by
their characteristic cell shapes.
Measurement of cytokine concentrations
The concentrations of each cytokine in the supernatant of the
BALfluidand serum were determined usingcommerciallyavailable
enzyme-linked immunosorbent assay (ELISA) kits (eBioscience, San
Diego, CA, USA) according to the manufacturer’s recommenda-
tions. Briefly, each well of a microplate was coated with 100 mLo f
thecapture antibodyand incubated overnight at 4uC. Afterwashing
and blocking the cells with assay diluent and BAL fluid, serum or
standard antibody was added to individual wells; the plates were
then maintained at room temperature for 2 h. The plates were
washed, and biotin-conjugated detecting antibody was added to
each well and incubated at room temperature for 1 h. The plates
were washed again and further incubated with avidin-horseradish
peroxidase for 30 min before antibody detection by using 3,39,5,59-
tetramethylbenzidine solution. Finally, reactions were stopped by
adding 1 M H3PO4, and the absorbance at 450 nm was measured
with an ELISA reader (Molecular Devices, Sunnyvale, CA, USA).
The amount of cytokine was calculated from the linear portion of
the generated standard curve [21,22].
Immunophenotyping
All monoclonal antibodies were purchased from eBioscience
(San Diego, CA, USA). T cells (CD3, 1:50), B cells (CD19, 1:50),
natural killer (NK) cells (DX5, 1:100), CD4+ T cells(CD4+, 1:160),
and CD8+ T cells (CD8+, 1:50) were identified using directly
conjugated anti-mouse antibodies. Briefly, blood was blocked with
Fc-block (eBioscience, San Diego, CA, USA) to reduce non-
specific antibody binding. Cells were then incubated in the dark
with 10 mL of the appropriate fluorochrome-conjugated antibody
for 20 min at 4uC. Cells were then washed with fluorescence-
activated cell sorter (FACS) buffer. The blood was lysed for 5 min
with FACS lysis buffer (BD Bioscience, Franklin Lakes, NJ, USA)
at room temperature and then re-washed with FACS buffer.
Finally, each sample was fixed with 1% paraformaldehyde until
further analysis. Flow cytometry analysis was performed using the
FACSCalibur system (BD Biosciences, Franklin Lakes, NJ, USA).
Control samples were matched for each fluorochrome. Data were
analyzed using CellQuest software (Becton Dickinson, Franklin
Lakes, NJ, USA) [21,22].
Measurement of histamine concentration
Histamine concentration was measured using a mouse hista-
mine ELISA kit (Wuhan EIAab Science Co., LTD., Wuhan,
Toxicological Effects of DEPs
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adding100 mLofstandard,blank,orsampleperwell,theplateswere
incubated for 2 h at 37uC. The liquid was removed from each well;
detectionreagentAworkingsolutionwasaddedtoeachwell;andthe
plate was incubated at 37uC for 1 h. After washing, detection
reagent B working solutionwas added toeachwell,and the plate was
incubated at 37uC for 1 h. After re-washing, the substrate solution
was added to each well and incubated at 37uC for 15 min, without
exposure to light. Finally, the reaction was terminated by the
addition of stop solution, and the absorbance was measured at
450 nm by using a microplate reader (Molecular Devices, Sun-
nyvale,CA,USA).Theamountsofsecreted collagenwerecalculated
from the linear portion of the prepared standard curve.
Protein expression in tissue
Lung tissue was homogenized with a protein extraction solution
(PRO-PREP
TM, Cat. No. 17081, iNtRON biotechnology,
Kyunggi, Korea), and lysates were centrifuged at 13,000 rpm for
10 min. The protein concentration was measured by the Bradford
method (Bio-Rad Protein Assay, Bio-Rad Laboratories Inc,
Hercules, CA), and equal amounts of proteins (40 mg) were
separated on a SDS/1%-polyacrylamide gel, and then transferred
to a nitrocellulose membrane (Hybond ECL, Amersham Pharma-
cia Biotech Inc., Piscataway, NJ, USA). Blots were blocked for 2 h
at room temperature with 5% (w/v) non-fat dried milk in Tris-
buffered saline [10 mM Tris (pH 8.0) and 150 mM NaCl]
solution containing 0.05% Tween-20. The membranes were
immunoblotted with the following primary specific antibodies:
rabbit polyclonal antibodies to COX-2 (1:500 dilution, Cayman
Chemical, MI, USA) and phospho-p53 (1:1000 dilution, Cell
Signaling Technology, Inc. Beverly, MA, USA); rabbit monoclo-
nal antibody to b-actin (1:2000 dilution, Cell Signaling Technol-
ogy, Inc. Beverly, MA, USA); mouse monoclonal antibodies to p-
STAT3, p-IkBa (both, 1:200 dilution, Santa Cruz Biotechnology
Inc. CA, USA), mesothelin, p53 (both, 1:1000 dilution, Santa
Cruz Biotechnology Inc. CA, USA), iNOS (1:1000 dilution, BD
Biosciences, CA, USA), and RANTES (1:4 dilution, eBioscience,
San Diego, CA, USA); and goat polyclonal to TGFb1 (1:1000
dilution, Santa Cruz Biotechnology Inc. CA, USA). The blot was
then incubated with the corresponding conjugated anti-mouse,
anti-rabbit, and anti-goat IgG-horseradish peroxidase (1:2000
dilution, Santa Cruz Biotechnology Inc.). Immunoreactive pro-
teins were detected using the electrochemiluminescence Western
blotting detection system.
Statistical analysis
DEP-treated groups were compared to those obtained from the
control group. The values were compared using Dunnett’s t-test
after one-way ANOVA, and the levels of significance were
determined by comparison with the control group.
Results
Properties of DEPs
The DEPs investigated in this study were found to be slightly
aggregated particles of diameter 1 mm, comprising small particles of
diameter 20 nm (Fig. 1A); the DEPs were a mass of metal oxide
compounds,whicharegenerallyformedwhendieselisburnt(Fig.1B).
DEPs were found to have a surface charge of 239.160.8 mV and a
hydrophilic surface because of the presence of oxides (Fig. 1C).
Change in body weight by DEPs
Before exposure to DEPs, the mean body weight in the control
and DEP-treated groups were 32.461.3 g and 32.461.4 g,
respectively (Fig 2). On day 28 after treatment, the mean body
weight in the DEP-treated group (37.562.38 g) was significantly
lesser than that in the control group (38.862.48 g).
BAL fluid composition
The total number of cells in the BAL fluid was significantly
greater in the DEP-treated mice than in the controls: the value in
thecontrolgroup was(0.0560.00)610
5 cells,while that in the DEP-
treatedmice examined on days1,7, 14, and 28 aftertreatment were
(0.6860.08), (0.3760.07), (0.1460.03), and (0.0860.01)610
5 cells,
respectively (Fig. 3A). The percentage of macrophages in the BAL
fluid decreased rapidly on day 1 (81.762.1%), and continued to
decrease over time (Fig. 3B). At all the defined time points, the
percentage of neutrophils in the BAL fluid samples of DEP-treated
micewas significantly greaterthan that inthecontrols: in controls, it
was 0.160.1% and in DEP-treated mice examined on days 1, 7, 14,
and 28 after treatment, it was 18.362.1%, 8.361.2%, 5.462.4%,
and 2.461.0%, respectively. On day 7, the percentage of
lymphocytes was significantly greater in the DEP-treated mice
(7.1360.51%) than in the controls.
Cytokines in BAL fluid
As shown in Table 1, the concentrations of the proinflammatory
cytokines, IL-1, TNF-a, and IL-6, were significantly greater in the
DEP-treated mice than in the controls at all the time points; in
particular, the DEP-treated mice exhibited an obvious increase in
the concentration of TNF-a from day 1 to day 14 after treatment.
Similarly, the IL-6 concentration in the BAL fluid of DEP-treated
mice was 2.7-fold that in the control mice on day 1. In addition,
the levels of IL-12 peaked on day 7 and were greater than that in
the control by about 3.3-, 10.4-, 8.6-, and 1.4-fold on days 1, 7, 14,
and 28 after treatment, respectively. The concentration of IFN-c
was 2.5-fold that in the control on day 1 after treatment. At all
time points, the concentrations of the Th2-type cytokines, IL-4,
IL-5, IL-10, and IL-13 as well as IL-17 were also significantly
greater in the DEP-treated mice than those in the controls, but the
increase in the concentration of these cytokines were lower than
that of the Th1-type cytokines.
Phagocytosis of DEPs by cells in BAL fluid
Figure 4 shows an image of cells in the BAL fluid harvested at
each time point. As shown in Figure 3, DEPs were suspended in
BAL fluid until day 14 after treatment and were partially
distributed in the cytoplasm of cells. Phagocytosis by immune
cells in BAL fluid was completed on day 28 after treatment, which
was indicated by the mainly cytoplasmic and partially nuclear
distribution.
Protein expression in lung tissue
Protein expression of RANTES, p53, and phospho-p53 in lung
tissue increased in a time-dependent manner and that of TGF-b
was clearly induced only on day 28 after treatment (Fig. 5). The
concentration of inducible nitric oxide synthatase (iNOS)
increased significantly during the experimental period and peaked
on day 7 after treatment, whereas expression of COX-2 was
upregulated from day 1 to day 14 after treatment. The effect of
DEP exposure on the expression of mesothelin protein was
minimal. The protein expression levels of p-IkBa, p-STAT3, and
NFkB p65 peaked on day 14 after treatment.
Cytokines in the blood
As shown in Table 2, the levels of the proinflammatory
cytokines, IL-1, TNF-a, and IL-6 were significantly greater than
Toxicological Effects of DEPs
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after treatment and were about 4.1-, 2.1-, and 12.8-fold,
respectively. The levels of IL-12 peaked on day 7 (2.1-fold that
in the controls) after treatment. The levels of IL-4 and IL-5 also
peaked on day 7 after treatment and were 3.6- and 5.2-fold,
respectively. The levels of IL-2 and IL-17 remained almost the
same throughput the experimental period.
Secretion of TGF-b and histamine
TGF-b levels in blood were significantly greater than that in the
controls at all time points, whereas the levels of TGF-b in BAL
fluid were significantly greater than those in the controls only on
day 28 after treatment (Fig. 6). Blood levels of TGF-b were
9.3560.14, 3.0560.05, 5.0860.06, and 23.8160.76 pg/ml on
days 1, 7, 14, and 28 after treatment, respectively, while that in the
controls was 1.1260.00 pg/ml.
The post-treatment levels of histamine in the BAL fluid and
blood were significantly greater than that in the controls (Fig. 7).
The level of histamine in the BAL fluid was almost the same as
that in the control throughout the experimental period (1.2- to 1.3-
fold that in the control). The blood levels of histamine were
13.760.5, 11.960.8, 7.260.1, and 7.860.2 pg/ml on days 1, 7,
14, and 28 after treatment, while the level in the controls was
5.160.02 pg/ml.
Cell composition of lymphocytes
As shown in Table 3 and Figure 8, the cell distribution of
lymphocytes shifted to a T-cell-dominant direction with the
Figure 1. Physicochemical properties of DEPs suspended in PBS. (A) TEM image, (B) Energy-dispersive X-ray spectroscopy, and (C) FT-IR
image.
doi:10.1371/journal.pone.0026749.g001
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exposure and on days 1, 7, 14, and 28 after exposure. *P,0.05.
doi:10.1371/journal.pone.0026749.g002
Figure 3. Changes in the cell distribution in BAL fluid after instillation of DEPs (n=4). Mice were administered a single intratracheal
instillation of DEPs at a dose of 10 mg/kg and then killed on the designated day (1, 7, 14, or 28 days after exposure). The cells in the BAL fluid were
quantified by hemocytometric counting (A), and the distributions of alveolar macrophages, neutrophils, and lymphocytes were assessed on the basis
of their characteristic cell shapes (B). The cell number in each group was expressed as mean 6 SD. *; P,0.05, **; P,0.01.
doi:10.1371/journal.pone.0026749.g003
Toxicological Effects of DEPs
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dominant direction with the recovery of the ratio of CD4+/CD8+
on day 7 after treatment. On day 14, the ratio of CD4+/CD8+
cells were clearly increased, implying an increase in the number of
CD4+ T cells; however, the distribution of T and B cells did not
change significantly. Furthermore, a significant increase in the
number of NK cells was shown during the experimental period.
Discussion
Exposure to DEPs is an environmental and occupational health
concern, and epidemiological, clinical and toxicological data
indicate that exposure to DEPs induces both hypersensitive disease
and cancer. Considering the fact that hypersensitive disease and
cancer involve different immune responses, we investigated the
relationship between the physicochemical properties of DEPs and
the biological responses induced by DEP exposure.
DEPs are composed of a carbonaceous core with adsorbed
organic compounds, sulfates, and trace elements. Soluble organic
compounds, including PAHs, can represent up to 60% of the mass
of the particle. The main targets of DEPs introduced into the body
via the bronchial tubes are immune cells in the BAL fluid and
airway epithelial cells. The human epithelium contains several
types of polarized cells with specific functions. The permeability of
Table 1. Changes in the cytokine levels in BAL fluid after a single instillation of DEPs (n=4).
Control Day 1 Day 7 Day 14 Day 28
IL-1 11.8660.92 19.8463.29* 20.4864.34* 16.9361.63* 17.2862.09*
TNF-a 13.2560.86 54.0064.43** 33.2465.57** 42.1865.37** 19.8961.48*
IL-6 42.7161.40 115.98610.73** 76.9264.91** 58.4361.59* 56.9564.22*
IL-2 19.5560.70 26.5261.91* 29.1365.39* 27.0760.93* 24.9264.53
IL-12 11.1860.82 37.3867.81* 116.56632.82* 96.40621.36* 16.1561.79*
IFN-c 13.3160.46 33.4264.64** 19.9163.47* 18.9861.14* 16.0061.31
IL-4 22.2463.57 27.3964.59 26.1663.10 25.0761.35 29.8363.17
IL-5 32.1161.95 36.4164.03 49.7962.02* 34.6963.01 36.7063.54
IL-10 54.7061.53 95.7266.93** 97.2666.51** 80.8864.86* 103.2066.85**
IL-13 26.9264.50 33.1868.33* 56.0167.74* 48.7667.08* 38.6563.54*
IL-17 75.6360.96 106.9464.49* 127.7065.83** 117.4063.45** 119.1764.29**
Note: BAL fluid was harvested at each time point and pooled (500 mL per mouse) to 4 test samples per group for further analysis. The level in each group was calculated
as mean 6 SD of the values measured.
*P,0.05;
**P,0.01.
doi:10.1371/journal.pone.0026749.t001
Figure 4. Images of cells in BAL fluid after a single instillation of DEPs. Mice were administered a single intratracheal instillation of DEPs at a
dose of 10 mg/kg, and BAL fluid samples were harvested on the designated days: (A) control, (B) 7 days, (C) 14 days, and (D) 28 days after exposure.
The results were confirmed from all the mice used, and representative images are shown.
doi:10.1371/journal.pone.0026749.g004
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and to a lesser extent on its molar mass [23]. Therefore, neutrally
charged, small particles may pass the cell membrane more easily
than charged, large ones. In our previous study on PM2.5, the
particle size in PBS was 909.96318.4 nm, with a surface charge/
conductance of 23.71 mV/30500 mS and an average mobility of
20.29 (m/s)/(V/cm); the particles were composed of toxic heavy
metals, such as Cr, As, Cd, and Pb, as well as other ionic
components. PM2.5 instilled via the trachea was easily engulfed by
the immune cells in the BAL fluid on day 1 after treatment and
consistently induced a Th1-type inflammatory response, along
with a slight increase in subG1 phase cells and an increase in the
expression of CD8+ T cells (CD4+ T cell on day 1 after
treatment). In this study, the surface charge of DEPs in PBS was
238.37 mV and the heavy metals on the surface were relatively
non-toxic. In addition, the DEPs were not completely engulfed by
the immune cells in the BAL fluid until day 14 after treatment and
induced a confused immune response during the experimental
period. The total cells in BAL fluid increased at all times tested,
indicating that DEPs did not induce apoptosis or necrosis.
The rapid increase in the burden of hypersensitive disease has
undeniably occurred in parallel with rapid industrialization and
urbanization in many parts of the world. Several studies have
shown that DEPs act as adjuvants to allergens and hence increase
the sensitization response [2,3,4,24]. Furthermore, Ma and Ma
(2002) reported that the organic component of DEPs may skew the
immunity toward a Th2 response, whereas the particulate
component of DEPs may stimulate both the Th1 and Th2
responses. In this study, DEP exposure was found to cause an
obvious increase in the TNF-a levels in the BAL fluid to 4.1-fold
that in the control, with a marked increase in CD8+ T-cell
distribution on day 1 after treatment, but induced B-cell
dominance with rapid recovery of the ratio of CD4+/CD8+ T
cells on day 7. In addition, on day 7, the concentrations of IL-1,
IL-6, and IL-5 in the blood were 4.1-, 12.8-, and 5.2-fold that in
the control, respectively, whereas the IL-12 concentration in the
BAL fluid increased to 10.4-fold that in the control. Considering
the fact that the cellular response in the blood stream was caused
by exposure to DEPs engulfed by immune cells, we suggest that
the changes observed from day 1, i.e., Th1-type inflammatory
response and CD8+ T-cell dominance, may have been effected by
the surface charge and surface chemicals, and those from day 7,
i.e., Th2-type inflammatory response, may be attributed to the
release of the soluble chemical components of DEPs engulfed into
immune cells. Our suggestions are supported by the rapid decrease
in the levels of IL-12 and the rapid increase in the levels of IL-10
and IL-17 in the BAL fluid after complete phagocytosis of DEPs
by immune cells in the BAL fluid on day 28. However, there is a
possibility that other cells in the lung including epithelial cells will
also release some cytokines and measurement in BAL fluid cannot
differentiate them from immune cells. Furthermore, the cell
Table 2. Changes in the cytokine levels in the blood after a single instillation of DEPs (n=4).
Control Day 1 Day 7 Day 14 Day 28
IL-1 4.3060.03 8.6360.07** 17.6060.50** 10.3060.12** 7.7060.07**
TNF-a 3.9260.04 6.7860.07** 8.2860.13** 7.4560.02** 6.7860.11*
IL-6 4.2160.11 10.9460.12** 53.7968.32** 24.6060.19** 8.7560.28**
IL-2 ND 1.8360.01 0.9760.00 0.9760.00 0.7560.00
IL-12 57.5461.76 77.7467.41* 117.43628.83* 69.11613.62* 92.08618.29*
IFN-c ND ND ND ND ND
IL-4 1.1460.02 2.8560.02** 4.0760.06** 3.3460.03** 2.0360.01*
IL-5 3.0060.02 5.1560.02* 15.4560.36** 4.2960.02* 4.2960.01*
IL-10 ND ND ND ND ND
IL-13 ND ND ND ND ND
IL-17 25.1762.24 30.4960.70* 30.5661.82* 29.4861.64 28.8261.10
Note. Serum was harvested on each time point and pooled (500 mL per mouse) to 4 test samples per group for further analysis. The level in each group was calculated as
the mean 6 SD of the values measured.
*P,0.05;
**P,0.01.
doi:10.1371/journal.pone.0026749.t002
Figure 5. Changes in the protein expression in lung tissue after
a single instillation of DEPs. Results were confirmed by several
separate experiments, and representative images are shown.
doi:10.1371/journal.pone.0026749.g005
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26749Figure 6. Levels of TGF-b in BAL fluid and blood after a single instillation of DEPs (n=4). BAL fluid and serum samples were harvested and
pooled on days 1, 7, 14, and 28 after DEP instillation, and pooled (500 mL per mouse) to 4 test samples per group for further analysis, respectively. The
levels in each group were calculated as mean 6 SD of the values measured. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0026749.g006
Figure 7. Levels of histamine in BAL fluid and in blood following a single instillation with DEPs (n=4). BAL fluid and serum were
harvested and pooled on day 1, 7, 14, and 28 after DEP instillation. The level in each group was expressed as the mean 6 SD of the values measured.
*P,0.05; **P,0.01.
doi:10.1371/journal.pone.0026749.g007
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immune cells and parenchymal cells will undergo apoptosis and
necrosis. These may change the cell composition in the lung,
thereby resulting in the release of cytokines.
Ma and Ma (2002) also reported that both the organic and
particulate components of DEPs exhibit different biological
actions, but both induce cellular oxidative stress. Together, these
effects exacerbate respiratory allergy and induce DNA damage,
eventually leading to the development of lung tumors. Further, the
oxidative stress mediated by DEPs may be induced via various
mechanisms, such as the direct generation of ROS from the
surface of particles; release of soluble compounds, such as
transition metals or organic compounds; altered function of
mitochondria or NADPH-oxidase, and activation of inflammatory
cells capable of generating ROS and reactive nitrogen species
[25,26]. Furthermore, the increase in the mutations induced by
DEP was significantly reduced by concurrent treatment with
phagocytosis inhibitors [20]. In this study, expression of transcrip-
tional proteins, such as p-IkBa, pSTAT3, and p65, peaked on day
14, whereas the expression of p53, phospho-p53, RANTES, and
TGF-b in lung tissue peaked on day 28, after a slight time-
dependent increase after DEP exposure. One of the major
functions of TGF-b is the inhibition of growth through the
blockage of the cell cycle in the late-G1 phase and inflammatory
resolution by immune suppression. The most fundamental
function of p53 is to serve as an essential growth checkpoint for
protecting cells against cellular transformation, thereby resulting in
blockage of the cell cycle [27,28,29,30]. The phospho–p53
complex is the active form of p53, and RANTES has chemotactic
activity for monocytes/macrophages, T cells, eosinophils, and
basophils [31]. In addition, the expression of iNOS increased
clearly until day 28 after DEP exposure, whereas that of
cyclooxygenase-2 (COX-2) increased until day 14 after DEP
exposure. COX-2 is the inducible isoform of COX, which is a key
enzyme in the conversion of arachidonic acid to prostaglandins
and other eicosanoids. iNOS is the inducible isoform of NOS,
which is the enzyme that catalyzes the formation of nitric oxide, a
regulator of vascular permeability. Both COX-2 and iNOS are
inducible by oxidative stress, and iNOS is inducible by COX-2.
p53 also downregulates the angiogenic process at various levels
[32,33].
Furthermore, in this study, all cytokines, except TNF-a and IL-
12, were measured in the BAL fluid; in particular, the levels of
Th2-type cytokines showed a slight increase after DEP exposure
until day 14. DEPs were not completely engulfed by immune cells
Table 3. Lymphocyte phenotypes in blood after DEPs
instillation (n=4).
Control DAY 1 DAY 7 DAY 14 DAY 28
NK 0.160.1 0.460.1* 0.660.2* 0.760.1** 0.760.4*
NKT 0.060.0 0.260.0* 0.660.6 0.260.1 0.360.2
T 61.263.4 80.967.0* 41.068.9* 54.865.6 58.365.8
B 38.763.5 18.667.0* 57.768.1* 44.365.6 40.666.1
CD4+/CD8+ 4.360.1 2.760.2* 4.060.5 5.660.5* 4.560.5
Note: The level in each group is the mean 6 SD of value was measured at each
time point.
*; P,0.05,
**; P,0.01.
doi:10.1371/journal.pone.0026749.t003
Figure 8. The levels of cell phenotype in blood following a single instillation with DEPs (n=4). Whole blood was harvested from 16 mice
on day 1, 7, 14, and 28 after DEP instillation, and pooled to make 4 samples for cell phenotype analysis. (A) control, (B) day 1, (C) day 7, (D) day 14.
doi:10.1371/journal.pone.0026749.g008
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the blood stream, thereby inducing Th2-type inflammatory
responses on day 7 after DEP exposure. The expression of p53,
phospho-p53, and TGF-b in lung tissue peaked on day 28, by
which time DEPs had been completely engulfed by the immune
cells in the BAL fluid. On day 14, a B-cell-dominant trend was
absent, despite phagocytosis of DEPs by the immune cells in the
BAL fluid and transference of the particles into the blood stream.
The ratio of CD4+/CD8+ T cells showed a trend towards greater
concentration of CD4+ T cell since day 1, despite the consistent
and significant post-treatment increase in the distribution of NK
cells expressing markers of CD8+ T cells. In addition, the levels of
TGF-b increased again in both BAL and blood, whereas the level
of histamine was increased again in the BAL fluid only from day
14 onwards. On the basis of the results of this study, we also
suggest that DEPs engulfed by immune and epithelial cells may
induce an early hypersensitive response and subsequent DNA
damage triggered by the breaking down and release of the soluble
chemical components of DEPs in cells.
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